RV658

RV658 · Respivert Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RV658, covering 2010-12-06 to 2010-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis [Phase 2]